DOCSLIB.ORG

List of Participants

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
List of Participants LIST OF PARTICIPANTS AT THE 11th ANNUAL GENERAL MEETING & CONFERENCE OF THE DEVELOPING COUNTRIES VACCINE MANUFACTURERS NETWORK ON 13 – 16 SEPTEMBER 2010, AT NOVOTEL CONVENTION CENTER, HYDERABAD, ANDHRA PRADESH, INDIA. MEMBERS OF THE DCVMN: Organization S.No. Name of the Member Organization No. 1 1 Dr. Ella, Krishna, M Bharat Biotech International Limited, Chairman & Managing Director Genome Valley, Shameerpet (M), Hyderabad, Andhra Pradesh, India. 500 078 2 Dr. Krishna Mohan, V Bharat Biotech International Limited President Genome Valley, Shameerpet (M), Hyderabad, Andhra Pradesh, India. 500 078 3 Mr. Prasad, Sai D. Bharat Biotech International Limited, Vice President Genome Valley, Shameerpet (M), Hyderabad, Andhra Pradesh, India. 500 078 4 Dr. Harshavardhan, G.V.J.A Bharat Biotech International Limited, Director - Rotavirus Vaccine Genome Valley, Shameerpet (M), Development Project Hyderabad, Andhra Pradesh, India. 500 078 5 Dr. Srinivas, V.K Bharat Biotech International Limited, Vice President Genome Valley, Shameerpet (M), Hyderabad, Andhra Pradesh, India. 500 078 6 Dr. Kamaraj, G Bharat Biotech International Limited, General Manager: Production Genome Valley, Shameerpet (M), Hyderabad, Andhra Pradesh, India. 500 078 7 Mr. Gopinathan, K Bharat Biotech International Limited, Assistant General Genome Valley, Shameerpet (M), Manager, Quality Control. Hyderabad, Andhra Pradesh, India. 500 078 8 Mr. Venkatesan, R Bharat Biotech International Limited, Assistant General Manager, Genome Valley, Shameerpet (M), Production. Hyderabad, Andhra Pradesh, India. 500 078 2 9 Ms. Datla, Mahima Biological E. Limited, Sr. Vice President 18/1&3, Azamabad, Hyderabad, India. 500 020 10 Mr. Mantena, Narender Dev Biological E. Limited, Sr. Vice President – SBD 18/1&3, Azamabad, Hyderabad, India. 500 020 11 Mr. Rayasam (Ray) Prasad Biological E. Limited, Chief Operating Officer 18/1&3, Azamabad, Gloabal Biologics Hyderabad, India - 500 020 12 Mr. Mahesh Kulkarni Biological E. Limited, Vice President , Quality Assurance 18/1&3, Azamabad, Hyderabad, India - 500 020 13 Dr. Mahesh Balghat Biological E. Limited, Vice President, Quality Control. 18/1&3, Azamabad, Hyderabad, India - 500 020 14 Ms. Sofi Joseph Biological E. Limited, Assistant General Manager, 18/1&3, Azamabad, Regulatory Affairs Hyderabad, India - 500 020 15 Mr. Giridhar Rao Biological E. Limited, Deputy Manager, Quality Assurance. 18/1&3, Azamabad, Hyderabad, India - 500 020 16 Dr. L. R. Sood Biological E. Limited, Sr. Vice President. 18/1&3, Azamabad, Hyderabad, India - 500 020 17 Mr. Benjamin Stephen Biological E. Limited, DGM - Quality Control Plot No.1, Phase II, SP Biotech Park, Genome Valley, Kolthur Village, Shameerpet Mandal, R.R. Dist. Andhra Pradesh. India - 500 078 3 18 Dr. Homma, Akira BioManguinhos / Fiocruz, Chairman of Policy and Strategy Council Rio de Janeiro Avenida Brasil, 4635 Manguinhos, Rio de Janeiro, Brazil. 21040-360 19 Dr. Leal, Maria da Luz Fernandes BioManguinhos / Fiocruz, Deputy Director of Quality Rio de Janeiro Avenida Brasil, 4635 Manguinhos, Rio de Janeiro, Brazil. 21040-360 20 Mr. Couto, Artur BioManguinhos / Fiocruz, Roberto Director Rio de Janeiro Avenida Brasil, 4635 Manguinhos, Rio de Janeiro, Brazil. 21040-360 21 Dr. Freire, Marcos da Silva BioManguinhos / Fiocruz, Deputy Director Technological Rio de Janeiro Avenida Brasil, Development 4635 Manguinhos, Rio de Janeiro, Brazil. 21040-360 4 22 Dr. Suhardono, Mahendra PT. Bio Farma (Persero), Production Director JI. Pasteur 28, Bandung, Indonesia. 40161. 23 Mr. Mas Rahman Roestan PT. Bio Farma (Persero), Corporate Secretary JI. Pasteur 28, Bandung, Indonesia. 40161. 5 24 Mr. Vonghangool, Vitoon Bionet-Asia Co.Ltd., Managing Director 889 Thai cc Tower, 10th Floor, Room 103, South Sathorn, Bangkok 10120, Thailand. 25 Dr. Pham, Hong Thai Bionet-Asia Co.Ltd., Director 889 Thai cc Tower, 10th Floor, Room 103, South Sathorn, Bangkok 10120, Thailand. 26 Mr. Biswas, Arun International Bionet-Asia Co.Ltd., Business Director My Home Rainbow, Flat # 607 (indigo), 8-1-329/1, Tolichowki, Hyderabad 500 008, Andhra Pradesh. India. 6 27 Dr. Makhoana, Morena The Biovac Institute, Chief Executive Officer 15 Alexandra Road, Private Bag X3, Pinelands 7430, Cape Town 7405, South Africa. 28 Mr. Duyse, Richard van The Biovac Institute, Chief Operating Officer 15 Alexandra Road, Private Bag X3, Pinelands 7430, Cape Town 7405, South Africa. 29 Mr. Kahanovitz, Selwyn The LITHA Healthcare Group Limited, Group Chief Executive Officer 1, Manchester Road, Wadeville, 1428, P O Box 14374, Wadeville 1422, South Africa. 7 30 Dr. Leon, Samuel Ponce de Laboratorios de Biologicos y General Director Reactivos de Mexico (BIRMEX), Amores 1240, Col. Del Valle, CP 03100, Mexico City, Mexico – 03100 31 Dr. Catalan, Francisco Padilla Laboratorios de Biologicos y Commercial Deputy General Director Reactivos de Mexico (BIRMEX), Amores 1240, Col. Del Valle, CP 03100, Mexico City, Mexico – 03100 32 Ms. Lopez, Angelica Laboratorios de Biologicos y QC/QA Deputy General Director Reactivos de Mexico (BIRMEX), Mariano Escobedo No.20, Col. Popotla, Mexico city, Mexico – 11400 8 33 Dr. P.S.Maruthi Sai Cadila Pharmaceuticals Limited, Vice President 1389, Trasad Road, Dholka 387 810 R & D Biotech Dist.: Ahmedabad, Gujarat, India. 34 Mr. M. Jeevan Kumar Cadila Pharmaceuticals Limited Vice President: Commercial 1389, Trasad Road, Dholka 387 810 CPL Biologics Dist : Ahmedabad, Gujarat, India. 9 35 Dr. Hamdallah Zedan Egyptian Company for Production of Chairman & CEO Vaccines, Sera and Drugs, VACSERA, Giza, Egypt. 10 36 Mr. Sit Thirapakpoomanunt Director Government Pharmaceutical Organization, (Actiing), Biological Product Rama VI Rd. Ratchathewi, Department Bangkok 10400, Thailand. 37 Mr. Pattharachai Lakornrach Chief, Government Pharmaceutical Organization, JE Vaccine Section Rama VI Rd. Ratchathewi, Bangkok 10400, Thailand. 38 Dr. Somchaiya Government Pharmaceutical Organization, Surichan Researcher Rama VI Rd. Ratchathewi, Bangkok 10400, Thailand. 11 39 Dr. Leite, Luciana C.C Instituto Fundacao Butantan, Director of Center of Biotechnology Av.Vital Brasil 1500 0553-900, Sao Paulo, SP, Brazil. 12 40 Dr. G.S. Reddy Indian Immunologicals limited, Chief General Manager Road No. 44, Jubilee Hills, Hyderabad, Andhra Pradesh 500 033, India. 41 Mr. B. Venugopal Rao Indian Immunologicals limited, Manager - Quality Assurance Road No. 44, Jubilee Hills, Hyderabad, Andhra Pradesh 500 033, India. 13 42 Ms. Kim, Sung Yeon S. LG Life Sciences Limited, th Product Manager 16 Floor, East Tower, LG Twin Towers, 20 Yoido-dong, Youngdungpo-gu, Seoul, R. of Korea, 150-791. 43 Dr. Choi, Doeg-Young LG Life Sciences Limited, Head/Vaccine Development SEOUL, LG Twin Towers, 20 Yoido-dong, Youngdungpo-gu, Seoul, R. of Korea, 150-721. 44 Dr. Deepali Mittal LG Life Sciences India Pvt Ltd, Assistant General Manager LG House, Plot No.11, Sector 44, Clinical Research Gurgaon 122001, India. 45 Dr. Mita Nandy LG Life Sciences India Pvt Ltd, Vice President LG House, Plot No.11, Sector 44, Medical Services & Clinical Research Gurgaon 122001, India. 14 46 Mr. Jain, Sumit Panacea Biotec Ltd, Director, Operations B-1, Extn/A-27, Mohan Co-op Industrial Estate, Mathura Road, New Delhi-110044, India. 47 Mr. Suri, Rajinder K Panacea Biotec Ltd, Chief Executive, Biologicals B-1, Extn/A-27, Mohan Co-op Industrial Estate, Mathura Road, New Delhi-110044, India. 48 Mr. Ahmed, Syed Panacea Biotec Ltd, Head, International Vaccine Business B-1, Extn/A-27, Mohan Co-op Industrial Estate, Mathura Road, New Delhi-110044, India. 49 Ms. Khanna, Navita Panacea Biotec Ltd, GM, Institutional Business Vaccine B-1, Extn/A-27, Mohan Co-op Industrial Estate, Mathura Road, New Delhi-110044, India. 50 Ms. Khalid, Sonia Panacea Biotec Ltd, Assistant General Manager B-1, Extn/A-27, Mohan Co-op Industrial Estate, Mathura Road, New Delhi-110044, India. 15 51 Dr. Cyrus S. Poonawalla Serum Institute of India Ltd, Chairman & Managing Director 212/2 Hadapsar, Off Soli Poonawalla Road, Pune 411 028, India 52 Mr. Adar C. Poonawalla Serum Institute of India Ltd, Executive Director - Operations 212/2 Hadapsar, Off Soli Poonawalla Road, Pune 411 028, India. 53 Dr. Jadhav, Suresh S. Serum Institute of India Ltd, Executive Director 212/2 Hadapsar, Off Soli Poonawalla Road, Pune 411 028, India. 16 54 Mr. Xu, Wenqing Sinopharm CNBG: Shanghai Institute of Director of Vaccine Division II Biological Products, No.1262 Yan’an West Road Shanghai, China 20052. 17 55 Mr. Guo, Lijun Sinopharm CNBG: Changchun Institute of Vice Director Biological Products, No. 137, Xi’an Road, Changchun, China – 610023. 56 Mr. Xie, Yinglin CNBG: Changchun Institute of Biological Manager of import & export Dept. Products, No. 137, Xi’an Road, Changchun, China – 610023. 18 57 Ms. Zhou, Wei Sinopharm CNBG: Wuhan Institute of Biological Products, No. 9, Linjiang Street, Wuhan, China- 430060. 19 58 Ms. Wang, Hui Sinopharm, CNBG: Beijing Tiantan Manager of QA & QC Biological Products Limited, No. 4 San-jian-fang-nan-li, Chaoyang District, Beijing, China – 100024 20 59 Dr. Do Tuan Dat VABIOTECH, The Company for Vaccine Deputy Chief of R & D and Biological Production No.1 1, Yersin Street, 10000 Hanoi, Vietnam. 60 Mr. Trinh Tuan Viet VABIOTECH, The Company for Vaccine Researcher R & D and Biological Production No.1 1, Yersin Street, 10000 Hanoi, Vietnam 21 61 Dr. (Ms.) Ting, Wu Xiamen Innovax Biotech Medical Affairs, Manager Bio Xinyuan Road, Haichang, Xiamen, Fujian, China – 361022 62 Mr. Yongzhong, Gao Xiamen Innovax Biotech General Manager Bio Xinyuan Road, Haichang,
Load more

Recommended publications
  • Water Security in Peri-Urban South Asia Edited by Adapting to Climate Change & Urbanisation ANJAL PRAKASH and SREOSHI SINGH
    Water Security in Peri-urban South Asia Edited By Adapting to Climate Change & Urbanisation ANJAL PRAKASH AND SREOSHI SINGH Collaborative research partners Contributing authors INSTITUTE OF WATER AND FLOOD MANAGEMENT, PURNAMITA DASGUPTA, AMAN DEWAN, DILIP KUMAR DUTTA, BANGLADESH UNIVERSITY OF ENGINEERING AND TECHNOLOGY, PROSUN KUMAR GHOSH, SHAILI GUMMADILLI, HAMIDUL HAQ, DHAKA, BANGLADESH M SHAH ALAM KHAN, UTHPAL KUMAR, M SHAHJAHAN MONDAL, VISHAL NARAIN, ANJAL PRAKASH, PRANAY RANJAN, SOUTH ASIA CONSORTIUM FOR INTERDISCIPLINARY WATER RESOURCES STUDIES, REZAUR REHMAN, RAJESH SADA, ANUSHIYA SHRESTHA, HYDERABAD, INDIA ASHUTOSH KUMAR SHUKLA, SREOSHI SINGH CENTER FOR POST GRADUATE STUDIES, NEPAL ENGINEERING COLLEGE, KATHMANDU, NEPAL Copyright © 2013 SaciWATERs, South Asia Consortium for Interdisciplinary Water Resources Studies (SaciWATERs), B-87, 3rd Avenue, Sainikpuri, Secunderabad, India – 500 094 (www.saciwaters.org) ISBN 978-81-929178-0-1 No part of this publication may be reproduced or copied in any form without written permission. Citation: Prakash, Anjal and Sreoshi Singh (Eds). 2013. Water Security in Peri-urban South Asia: Adapting to Climate Change and Urbanisation. Hyderabad. SaciWATERs and IDRC. This project was supported by the International Development Research Center Canada. First Edition: June, 2013 (200 copies) Second Edition: January, 2014 Published by: SaciWATERs, India Book design: Somya Darshan Jee and Mohd Abdul Fahad Cover illustration: Somya Darshan Jee We would like to thank Dr. Kuntala Lahiri Dutt for critically looking
    [Show full text]
  • Susan M. Walcott.Pmd
    Indian Journal of Economics & Business, Special Issue China & India (2006) : 1-... HIGH TECHNOLOGY CLUSTERS IN INDIA AND CHINA: DIVERGENT PATHS SUSAN M. WALCOTT Georgia State University, Atlanta and JAMES HEITZMAN University of California, Davis The economic giants of Asia, India and China, encourage clusters of high technology companies to fuel their national economic development drives, but the paths of these neighbors follow divergent trajectories due to different interconnections between government policy and business strategy. Based on field research, economic data and targeted case studies, this article explores the impact of regional political agency, technology infrastructure (unconnected versus integrated), the central government (hands-off versus highly involved), private capital (large versus negligible), and foreign direct investment. The picture emerging from each countrys profile allows assessment of short and long-term change for these urban clusters. 1. THE TECHNOPOLE AND ASIAN URBANIZATION A growing body of multi-disciplinary scholarship focuses on technopoles: dynamic clusters of research and production organizations generating rapid employment growth within innovative sectors, forming an important component of public policy. The technopole effect - encompassing spin-offs from co-located science or business parks, the segregated enclaves of privileged employees, attractive recreational amenities, and enabling infrastructure - produces a characteristic urban morphology within an emerging category of technology-based world cities. The transformed environments where the technopole effect occurs, often defined as corridors, signify a major component in urban policy that aims at the stimulation of services on the borders of former urban cores. A clear need exists for examining such spaces of human interaction, based on case studies of new urban developments offering possibilities for global application (Grant and Nijman 2002).
    [Show full text]
  • Bharat Biotech Announces Successful Completion of Its Phase I/Ii Clinical Trial for 116E Rotavirus Vaccine
    BHARAT BIOTECH ANNOUNCES SUCCESSFUL COMPLETION OF ITS PHASE I/II CLINICAL TRIAL FOR 116E ROTAVIRUS VACCINE Press release dated: 28th May, 2008 The Indian Rotavirus Vaccine Development Project (RVDP) announced today encouraging results from a recent Phase I/II clinical trial of a live, natural reassortant, Oral Rotavirus Vaccine 116E (ORV 116E), conducted in New Delhi, India. RVDP is a collaborative effort with support and guidance from the Department of Biotechnology, Government of India; PATH; US Centers for Disease Control and Prevention (CDC); Stanford University; US National Institutes of Health, National Institute of Allergy and Infectious Diseases (NIAID); Society for Applied Studies; National Institute of Immunology, New Delhi; Indo-US Vaccine Action Program; All India Institute of Medical Sciences and Bharat Biotech International Limited. Rotavirus infections are the single largest cause of severe diarrheal disease among infants and children worldwide and cause more than 500,000 deaths in infants and children each year, with 90% of these deaths occurring in the world’s poorest countries. Rotavirus diarrhea causes more than 120,000 deaths in India alone. The Phase I/II trial was designed as a Double-blind Randomized Placebo Controlled Dose Escalating Study of ORV 116E in healthy non-malnourished infants 8-20 weeks of age with safety and immunogenicity as the primary and secondary objectives, respectively. The study was conducted by the Society for Applied Studies in New Delhi. The doses selected for administration were 104.0 and 105.0 FFU with reactogenicity, immunogenicity and viral shedding as the study endpoints. One-hundred and eighty-seven infants were enrolled for the 104.0 FFU dosage and 182 were enrolled for the 105.0 FFU dosage.
    [Show full text]
  • Related Parliamentary Standing Committee on Science & Technology, Environment & Forests to Hyderabad on January 9, 2014
    Material for Study Visit of the Department - related Parliamentary Standing Committee on Science & Technology, Environment & Forests to Hyderabad on January 9, 2014 Ministry of Environment & Forests Govt. Of India Hyderabad General Hyderabad is the capital and largest city in Andhra Pradesh situated on the banks of the Musi River at coordinates of 17.366°N 78.476°E. It occupies 650 square kilometres (250 sq mi) and with a metropolitan population of near 8 million, it is fourth most populous city and sixth most populous urban agglomeration in India. In 1956, the Telangana region of Hyderabad State was merged with Andhra State to form the modern state of Andhra Pradesh, with Hyderabad city as its capital. Historically, Hyderabad was known for its pearl and di amond trading centres. Industrialisation brought major Indian manufacturing, research, and financial institutions to the city, such as the Bharat Heavy Electricals Limited, the Defence Research and Development Organisation, the National Remote Sensing Centre, the National Geophysical Research Institute, the Centre for Cellular and Molecular Biology and the National Mineral Development Corporation. The formation of an information technology (IT) Special Economic Zone s (SEZs) by the state agencies attracted global and Indian companies to set up operations in the city. The emergence of pharmaceutical and biotechnology industries and the formation of Genome Valley during the 1990s earned it the title "India's pharmaceutical capital". The city has 140 lakes and 834 water tanks. The main lakes include Husain Sagar, built in 1562 near the city centre, Osman Sagar and Himayat Sagar, which are artificial lakes created by dams on the Musi and these two reservoirs constitute the major drinking water source of Hyderabad city.
    [Show full text]
  • State Plans to Set up World-Class Centre for Curative Therapies in Hyd
    2 TELANGANA KHAMMAM TUESDAY 18 FEBRUARY 2020 State plans to set up world-class centre for curative therapies in Hyd State Industry Minister K T Rama Rao says that government is committed to building capabilities of tomorrow and is planning to establish a world-class institution focussed on curative therapies in Hyderabad HANS NEWS SERVICE Hyderabad: Telangana Industry and IT Minister KT Rama Rao on Monday said that government was planning to establish a world-class institution focussed on curative therapies in Hyderabad, which Inter student’s death triggers would be engaged in a�ordable de- velopment and commercialisation of new age curative therapies (par- ticularly Cell and Gene Therapy). protest by parents at D-Mart The Minister inaugurated the 17th BioAsia convention here on second year in a private college Police personnel arrived on Monday. He said that government S Parents allege that the in Hayathnagar and staying in the spot and brought the situa- was committed to building capa- security staff of D-Mart the hostel. tion under control. Based on the bilities of tomorrow and was plan- store assaulted their son On Sunday night, along with complaint police registered a ning to establish a world-class in- accusing him of chocolate his three friends he had visited case and are investigating. They stitution focussed on curative the� the stores to make purchases. are verifying the CCTV footage therapies. The institution would State Industry and IT Minister KT Rama Rao speaking a�er inaugura�ng the 17th BioAsia conven�on in Hyderabad on Monday When he had done shopping, the to get clarity in the case and are be working for curative therapies S Demand ac�on against security sta� of the stores inquiring the security sta� and for the diseases pertinent to India entry of Syngene further consoli- change due to several factors in- clearances.
    [Show full text]
  • Trends in Vaccine Development
    ADVERTISEMENT FEATURE NATUREJOBS SPOTLIGHT ON VACCINES Trends in vaccine development How are public-private partnerships, low-cost manufacturers and new technology afecting the vaccine field? “The vaccine field BILL GATES is a handy person to grow over the next few years. the virus was identifed in 1984, to have in your corner, which In the United States, demand researchers were optimistic they is going to enlarge bodes well for those committed to will increase by around 7 percent could formulate a vaccine quickly. vaccine research. In January 2010 annually until 2015, according to a As HIV proved resilient, hopes for substantially beyond the philanthropist called for a 2011 report published by industry a fast response faded and by the SPOTLIGHT ON IMMUNOLOGY / VACCINES ON IMMUNOLOGY SPOTLIGHT “decade of vaccines” and pledged analysts Freedonia. “It’s probably early 1990s several research groups the traditional US$10 billion for vaccine research the best growth area right now in and companies had abandoned and development (R&D) and infectious disease,” says Steve Projan, the search for a vaccine. preventive vaccine.” distribution. Te Bill & Melinda senior vice president of R&D in It became clear that a new Gates Foundation funding will the innovative medicines unit at model of vaccine development was Rafi Ahmed, Emory Vaccine Center boost an already burgeoning feld. vaccine manufacturer MedImmune. needed, one that could bridge the Although vaccines comprise Te industry is being shaped by gap between the public and private a small portion of the global increased collaboration between the sectors and focus on the developing pharmaceutical market — 2 percent public and private sectors, the rise world.
    [Show full text]
  • Defence Aero&Space Be Competent
    Make in TVOLUME 02e ISSUE 07 HYlDERABAD JUaLY 2017 PAGESn 68 Rs. 100 A gMonthly Magazaine of Telanganna Industrialists Fa ederation (TIF) Special issue on Defence Aero&space Be competent Indigenisation is our priority Strategic City Contents Make In Telangana A monthly Magazine of Telangana Industrialists Federation (TIF) Editor-in-Chief a big leap K Sudhir Reddy Executive Editor M A Srinivasan a huge satisfaction Editor Mirupala Gopal Rao Editorial Board Singireddy Niranjan Reddy Tadakamalla Vivek Sunil Kumar Mohareer V B Shankar Dr Mahesh Y Reddy Reporting K Chandrasekhar J Srikanth 08 International Correspondents United States of America Harish S Reddy Canada 12 Mayank Chadha United Kingdom Spandana Ayachitam Legal Advisor S Bharath Kumar Circulation, Subscription & Distribution J Srikanth Be competent, if want to be Designed by Defence & Sahasra Graphics aerospace Hub For Editorial Content Email: [email protected] For advertisement & circulation Email: [email protected] Printed & Published by K Sudhir Reddy, on behalf of Telangana Industrialists Welfare Federation, Printed at Sree Designs, No. 9, GF, Prashanth Towers, Musheerabad, Hyderabad-500048 Publication Consultant Published at Telangana Industrialists Welfare Federation. H No 1-8-8/1, Ravindranagar Colony, K Raghurama Raju Habsiguda, Hyderabad – 500007, Telangana. 4 Make in Telangana i JUlY 2017 Indigenisation eTeclanogsanya sneteedsm an Unless a perfect ecosystem is developed Defence and is our priority Aerospace will not be able to flourish in Telangana, says Shiva Kumar , a leading entrepreneur voicing the industry’s concerns 22 30 Inaugural Flight Bombay- Aurangabad Capt M.D Mistry, S.S Rao,Radio Officer, Air Hostess 42 Early Birds OF 37 Hyderabad Skies Strategic City a heaven for Research & Development Need concessions 52 & nurturing a green estate 60 Make in Telangana i JUlY 2017 Make in Telangana i JUlY 2017 5 Editorial Three years of pride new state was born on 2 June 2014, after demol - ishing decades of servitude.
    [Show full text]
  • Genome Valley - Bio Intiatives - Hyd Knowledge City
    Genome Valley - Bio Intiatives - Hyd Knowledge City http://www.genomevalley.in/hydknowledgecity.htm HOME » BIO INITIATIVES » HYDERABAD KNOWLEDGE CITY Search THE HUB FOR YOUR BIOTECH PURSUITS Hyderabad The urban Eden - life at its best Home Recognised as the cleanest and best - lit city in the country, Hyderabad today, has metamorphosed from the Genome Valley Opulent city of the Nawabs and Zamindars into a bustling Metropolis. Replate with Cutting edge facilities Biotech Govt. Policy through harnessing Information Technology, a stable and Pro- citizen Government, healthy Regulations and a cost effective yet high Standard of living, the city offers an Unmatched lifestyle. Advisory Board Bio Initiatives Sprawling lifestyle shopping complexes and entertainment centers. BTIC Heritage and next generation clubs. Bio Resource Bio Funding Amusement parks, resorts, gaming centers and theme parks. Bio Infrastructure Preferred destination for international conferences and seminars. Hyderabad Knowledge City eSeva - computerized and integrated facilitator points for over 30 one - stop citizen services. Photo Gallery International connectivity. Biotech Players Careers Hyderabad today is the country's most preferred destination for new age technologies in the areas of Information Technology, Biotech and healthcare. Building on an established foundation of world-class Centres of Excellence infrastructure in R&D, manufacturing, healthcare and education, the state Government has initiated India's Downloads first Biotech Cluster in Hyderabad.... the Genome Valley , a geographic concentration of bioscience companies, R&D labs and medical institutions. Thus setting the stage for economic growth through Contact Us partnerships, collaborations and mutually beneficial objectives in Biotechnology. Links : ICICI knowledge park SP Biotech Park APIPR ANDHRAPRADESH.com CCMB CDFD IICT NIN Agri Science Park Copyright � 2002-04, Genome Valley.
    [Show full text]
  • The Federation of Telangana Chambers of Commerce and Industry List of Micro & Small Enterprises (Panel
    THE FEDERATION OF TELANGANA CHAMBERS OF COMMERCE AND INDUSTRY (Formerly known as FTAPCCI) Established in 1917 Regd. Under the Companies Act, 1956 LIST OF MICRO & SMALL ENTERPRISES (PANEL - E) MEMBERS as on 31st May, 2021 REGISTERED OFFICE Federation House, FTCCI Marg, 11-6-841, Red Hills, P.B.No.14, Hyderabad – 500 004. Phone Nos. : 91 40 23395515 to 24; Fax : 91 40 23395525 E-mail : [email protected] Web: www.ftcci.in CIN U91110TG1964NPL001030 ALPHABETICAL INDEX OF MEMBERS S.No Panel Name Page S.No Panel Name Page S.No Panel Name Page No. No. No. No. No. No. A 53 199 ASIAN HERBEX LTD. 10 C 54 1105 ASSOCIATED POWER TECH 1 949 3D FOAMCUT PVT. LTD. 35 PVT. LTD. 62 97 895 CALTECH ENGINEERING CO.(P) 2 658 A.G BIOTECK LABORATORIES 55 986 ASWARTHA CONDITION LTD. 60 (INDIA) LTD. 27 MONITORING ENGINEERS 36 98 1297 CANFLEX ENGINEERING 3 289 A.J.CANS PVT. LTD. 15 56 1230 ATOBA BUSINESS NETWORKS PVT.LTD. 54 4 912 A.P. POULTRY EQUIPMENTS 34 PVT. LTD. 64 99 1178 CARGOMEN LOGISTICS INDIA 5 1148 A.R. PHARMA 43 57 998 AVANTEL LTD. 37 PVT. LTD. 45 6 1115 ACARICIDE INDIA PVT. LTD. 41 58 664 AVANTI BUSINESS MACHINES 100 134 CENTUARY FIBRE PLATES LTD 28 7 463 ACCURATE ENGINEERS 21 PVT. LTD. 7 59 249 AVINEON INDIA PRIVATE LTD. 13 101 884 CHANDER BHAN & COMPANY 34 8 932 ACER ENGINEERS PVT.LTD. 35 60 1180 AVNITECH VENTURES PVT. LTD. 46 102 536 CHARMINAR FOODS AND 9 927 ACME TOOLINGS 35 EXPORTS PVT.
    [Show full text]
  • Jain Heritage a Cambridge School Surrounding Development
    Surrounding Development - Schools Jain Heritage a Cambridge School Shamirpet, Hyderabad. Syllabus CBSE Classes Nursery to XII Fees Rs.55k to 90k p.a. Transport facility to site Available Hostel facility Available Food service Available Sports facilities Cricket, Basket balll, Swimming Co-curricular activities Art, Dance, Music, Yoga Land area 5 acres Year of establishment 2012 Location Majeedpur, Shamirpet Contact no. 9348989808 Email ID [email protected] Distance from site 4.3 kms www.modiproperties.com * Information is not available Surrounding Development - Schools Ivy League Academy Shamirpet, Hyderabad. Syllabus CBSE Classes I to XII Fees Rs. 1.70 Lakh p.a. Transport facility to site Available Hostel facility Available Food service Available Sports facilities Cricket, Hockey, Football, Swimming Co-curricular activities Music, Theatre, Dance Land area 40 acres Year of establishment 1988 Location Bommarasipet, Shamirpet Contact no. 9052880335 Email ID [email protected] Distance from site 15 kms www.modiproperties.com * Information is not available Surrounding Development - Schools St.Mary's Central School Shamirpet, Hyderabad. Syllabus CBSE Classes Nursery to X Fees NA* Transport facility to site Available Hostel facility Not Available Food service Not Available Sports facilities Available Co-curricular activities Not Available Land area 2.23 acres Year of establishment 2001 Location Ashramam Road, Turkapally Contact no. 9652772004 Email ID [email protected] Distance from site 2..7 kms www.modiproperties.com * Information is not available Surrounding Development - Schools Vijetha Techno School Shamirpet, Hyderabad. Syllabus SSC Classes I to X Fees NA* Transport facility to site Available Hostel facility Not Available Food service Not Available Sports facilities Available Co-curricular activities NA* Land area 2 acres Year of establishment 2010 Location Turkapally Contact no.
    [Show full text]
  • Welcome NOTE President
    2015 welcome NOTE from the president EXECUTIVE COMMITEE MEMBERS Mr. Mahendra Suhardono President Bio Farma, Indonesia Mr. Rajender Kumar Suri Dr. Akira Homma Vice President Treasurer Panacea Biotech Limited, India Bio-Manguinhos (Fiocruz),Brazil Mr. Rayasam Prasad Ms. Meng Li Mr. Patrick Tippoo Biological E. Limited, India China National Biotec Group Co.Ltd., China The Biovac Institute, South Africa Mr. Juliman Dr. Steven Gao Mr. Adar Poonawalla GAVI Board Alternate Xiamen Innovax Biotech Co. Ltd., China GAVI Board Representative Bio Farma, Indonesia Serum Institute of India Ltd., India Member Organizations’ Geographical Presence Argentina Bangladesh Brazil Cuba Egypt India Indonesia IR of Iran Mexico P.R. China Republic of Korea Saudi Arabia South Africa Taiwan Thailand Vietnam Name of the company : Arab Company for Pharmaceutical Products (Arabio) Head of Institution : Dr. Majed Saeed Bahatheq (Arabio CEO) Established : Arabio is a limited liability company established in 2005 Location : Saudi Arabia Overview of the company Arabio is a biopharmaceutical company specialized in human vaccines, and other biopharmaceuticals. It is the first biopharmaceutical company in the Gulf Cooperation Council (GCC). The size and scope of activities intended to be made in Arabio would make Arabio the first biological company of its kind in the Middle East. Arabio aims to bring to the markets of the Middle East, North Africa, and high quality products that comply with the international quality standards. Arabio has production lines of pre-filled syringes, liquid vials and lyophilized vials from the best global machines suppliers to make high quality products and meet cGMP & international standards. Description of ARABIO capabilities – Biological sterile manufacturing – PFS and vial filling – PFS and vial blister packaging Arabio Partners: 1.
    [Show full text]
  • PDF: 300 Pages, 5.2 MB
    The Bay Area Council Economic Institute wishes to thank the sponsors of this report, whose support was critical to its production: The Economic Institute also wishes to acknowledge the valuable project support provided in India by: The Bay Area Council Economic Institute wishes to thank the sponsors of this report, whose support was critical to its production: The Economic Institute also wishes to acknowledge the valuable project support provided in India by: Global Reach Emerging Ties Between the San Francisco Bay Area and India A Bay Area Council Economic Institute Report by R. Sean Randolph President & CEO Bay Area Council Economic Institute and Niels Erich Global Business/Transportation Consulting November 2009 Bay Area Council Economic Institute 201 California Street, Suite 1450 San Francisco, CA 94111 (415) 981-7117 (415) 981-6408 Fax [email protected] www.bayareaeconomy.org Rangoli Designs Note The geometric drawings used in the pages of this report, as decorations at the beginnings of paragraphs and repeated in side panels, are grayscale examples of rangoli, an Indian folk art. Traditional rangoli designs are often created on the ground in front of the entrances to homes, using finely ground powders in vivid colors. This ancient art form is believed to have originated from the Indian state of Maharashtra, and it is known by different names, such as kolam or aripana, in other states. Rangoli de- signs are considered to be symbols of good luck and welcome, and are created, usually by women, for special occasions such as festivals (espe- cially Diwali), marriages, and birth ceremonies. Cover Note The cover photo collage depicts the view through a “doorway” defined by the section of a carved doorframe from a Hindu temple that appears on the left.
    [Show full text]